Articles from BIOTECH Patent News (August 1, 2000)

Title	Author	Type	Words
Biogen and Elan to collaborate on multiple sclerosis monoclonal antibody.		Brief Article	569
Biogen praises Court ruling that Avonex does not infringe Berlex 'McCormick' patents.		Brief Article	346
Biosytes awarded patent for Bio-Solv process for Q-Gel (Coenzyme Q10) Softsules.		Brief Article	246
Biotransport carriers could assist in discovery of new therapies from the human genome.		Brief Article	358
Cell Genesys exclusively licenses technology for liver-directed Aav gene therapy from University of Washington.		Brief Article	744
Collateral announces expanded angiogenic gene research collaboration with New York University.		Brief Article	437
Collateral announces issuance of United States patent for angiogenic gene therapy for the treatment of heart disease.		Brief Article	559
Eurogene and Valentis announce collaboration to develop gene medicine to inhibit restenosis.		Brief Article	489
Genta announces licensing deal for antisense technology to Sequitur.		Brief Article	307
Genvec announces broad gene therapy patent.		Brief Article	196
Genzyme Molecular Oncology licenses cancer diagnostic patent rights to three diagnostic laboratories.		Brief Article	648
Isis Pharmaceuticals' Genetrove division and the R.W. Johnson Pharmaceutical Research Institute initiate antisense target validation program.		Brief Article	432
McGill University grants exclusive license to Mycota Biosciences for novel fungal genomics technology.		Brief Article	411
Medarex and Athersys announce collaboration to develop human antibody therapeutics.		Brief Article	481
Novo Nordisk obtains United States patent.		Brief Article	158
Select Therapeutics announces research agreement with University of Arizona Cancer Center.		Brief Article	283
Sequenom and University of Texas Southwestern commence record Snp and disease association oroject.		Brief Article	843